Primary efficacy announcement from AstraZeneca: 76% (CI 68-82) - that's 15 days after 2nd dose. (That's what was pre-specified - a longer interval than other vaxes.)
It's based on a count of 190 events: 14 still being assessed...1/2
https://www.astrazeneca.com/media-centre/press-releases/2021/azd1222-us-phase-iii-primary-analysis-confirms-safety-and-efficacy.html … HT @AnitaN1007pic.twitter.com/5kK6gi7NHy